12 employees
Focal Therapeutics develops novel tissue-marking devices for use in surgery designed to mark the surgical site of tissue removal in 3D.
2007
$7.8M
from 1 investors over 1 rounds
Focal Therapeutics raised $7.8M on September 3, 2014
Investors: Okapi Venture Capital